share_log

Ligand Pharmaceuticals | PRER14A: Preliminary revised proxy soliciting materials

SEC ·  May 23, 2018 05:33
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.